Gene · 2243
Papers3,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness. | Cancer Res Commun | 2023 | 37501683 | PubTator, text mining | PubMed |
| Multi-layered genetic approaches to identify approved drug targets. | Cell Genom | 2023 | 37492104 | PubTator, text mining | PubMed |
| Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37489008 | PubTator, text mining | PubMed |
| Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19. | Heliyon | 2023 | 37483779 | PubTator, text mining | PubMed |
| DNA Polymorphism of 13 Autosomal Short Tandem Repeats (STR) Loci in Mentawai Populations. | Pak J Biol Sci | 2023 | 37480266 | PubTator, text mining | PubMed |
| Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols. | Stem Cell Reports | 2023 | 37478860 | PubTator, text mining | PubMed |
| Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer. | Biomark Res | 2023 | 37475010 | PubTator, text mining | PubMed |
| Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. | Nat Commun | 2023 | 37460463 | PubTator, text mining | PubMed |
| STRategy: A support system for collecting and analyzing next-generation sequencing data of short tandem repeats for forensic science. | PLoS One | 2023 | 37459339 | PubTator, text mining | PubMed |
| "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies. | Front Oncol | 2023 | 37448521 | PubTator, text mining | PubMed |
| Microchimerism as Post-Transplant Marker of a Chronic Rejection Process. | Int J Mol Sci | 2023 | 37445781 | PubTator, text mining | PubMed |
| Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis. | Hamostaseologie | 2023 | 37442158 | PubTator, text mining | PubMed |
| Identification of age- and immune-related gene signatures for clinical outcome prediction in lung adenocarcinoma. | Cancer Med | 2023 | 37434467 | PubTator, text mining | PubMed |
| Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. | Front Cell Dev Biol | 2023 | 37427373 | PubTator, text mining | PubMed |
| Concomitant hypofibrinogenemia and factor XI deficiency as rare cause of bleeding during urgent dentistry: case report and short review of the literature. | Arch Clin Cases | 2023 | 37405328 | PubTator, text mining | PubMed |
| Effects of solvent-based adhesive removal on the subsequent dual analysis of fingerprint and DNA. | Int J Legal Med | 2023 | 37402011 | PubTator, text mining | PubMed |
| Whole genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles. | medRxiv | 2023 | 37398003 | PubTator, text mining | PubMed |
| Clotting Factor Deficiencies as an Underlying Cause of Abnormal Uterine Bleeding in Women of Reproductive Age: A Literature Review. | Life (Basel) | 2023 | 37374104 | PubTator, text mining | PubMed |
| Allele Frequencies and Forensic Data of 25 STR Markers for Individuals in Northeast Brazil. | Genes (Basel) | 2023 | 37372365 | PubTator, text mining | PubMed |
| The Way to Malignant Transformation: Can Epigenetic Alterations Be Used to Diagnose Early-Stage Head and Neck Cancer? | Biomedicines | 2023 | 37371812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2243/papers?page=17